CT informs detection and treatment options in rheumatoid arthritis complicated by pulmonary non-tuberculous mycobacterial disease from the FIRST registry.
Masashi FunadaYusuke MiyazakiShingo NakayamadaKoshiro SonomotoYasuyuki TodorokiIppei MiyagawaHiroaki TanakaYoshiya TanakaPublished in: RMD open (2024)
CT screening before the initiation of molecular-targeted treatment enabled the detection of asymptomatic PNTM that was undetectable on plain radiographs. This study showed that molecular-targeted therapeutic drugs in combination with anti-NTM treatment could control the disease activity of both PNTM and RA.
Keyphrases
- rheumatoid arthritis
- disease activity
- systemic lupus erythematosus
- ankylosing spondylitis
- computed tomography
- rheumatoid arthritis patients
- dual energy
- pulmonary hypertension
- image quality
- cancer therapy
- loop mediated isothermal amplification
- magnetic resonance imaging
- interstitial lung disease
- magnetic resonance
- combination therapy
- positron emission tomography
- single molecule